G
Genevant Sciences
Cambridge, United States
Founded 2018
About
Lipid nanoparticle and ligand conjugate delivery platforms for genetic medicines
Company Details
- Type
- commercial
- Employees
- 100+
- Funding
- $200M+
Key Products
- LNP Platform
- GalNAc Conjugates